I agree. I don’t understand NP not addressing the TNBC trial delay for months now. It is unnecessary frustrating some investors. Have you ever seen those psych studies where they ask someone for $1 then $10 and they usually say no, but if you ask for $100 first than $10, they get more more yes. Perception is strange, the current method though, makes some feel nothing ever gets done because of these missed timelines, when it fact, lots of positives have happened over the last two years. The fda asking for 100 safety at 700mg really has aggrevated the situation much worse. We are months away from drug approval, which should be exciting times for the company, but that perception of nothing getting done is really hurting the stock. Hopefully the updates tomorrow changes that some.